(MedPage Today) — Patients with giant cell arteritis (GCA) in France were kept on glucocorticoids at worrisome levels that led to clinically significant adverse effects, insurance data indicated. Just looking at patients newly diagnosed in 2022…
Source: MedPage Today — Headlines
